Fortress Biotech, Inc. (FBIO) Financials

FBIO Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 356.9 million 154.5 million
Dec. 31, 2025 185.5 million 123.4 million
Sept. 30, 2025 181.4 million 116.2 million
June 30, 2025 159.9 million 122.5 million

FBIO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 203.9 million 1.8 million
Dec. 31, 2025 -12.5 million 2.5 million
Sept. 30, 2025 -6.1 million 3.2 million
June 30, 2025 -27.6 million 16.8 million

FBIO Net Income

No data available :(

FBIO Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 255.8 million 36.9 million 12.0 million
Dec. 31, 2025 79.4 million 59.5 million 14.8 million
Sept. 30, 2025 86.2 million 47.8 million 14.9 million
June 30, 2025 74.4 million 50.0 million 15.4 million

FBIO Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 38.4 million
Dec. 31, 2025 279.0 million
Sept. 30, 2025 33.1 million
June 30, 2025 29.8 million

FBIO Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 540000 15.9 million -
Dec. 31, 2025 - -367000 14.7 million -
Sept. 30, 2025 - 208000 17.4 million -
June 30, 2025 - 8.1 million 38.8 million -

FBIO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 16.0 million 7.3 million
Dec. 31, 2025 16.1 million 5.4 million
Sept. 30, 2025 17.6 million 5.8 million
June 30, 2025 16.4 million 4.9 million

FBIO Revenue by Segment
Graph available only for paid members. Upgrade to see it.

FBIO

Price: $2.61

52 week price:
1.70
4.53

Payout Ratio Range:
-62.12%
42.10%

Earnings Per Share: 3.23 USD

P/E Ratio: 0.77

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 340489

Ebitda: -32.4 million

Market Capitalization: 86.7 million

Links: